These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17920777)

  • 1. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of attention-deficit hyperactivity disorder for the future of the child and the young].
    Penttilä J; Rintahaka P; Kaltiala-Heino R
    Duodecim; 2011; 127(14):1433-9. PubMed ID: 21888044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.
    Halmøy A; Fasmer OB; Gillberg C; Haavik J
    J Atten Disord; 2009 Sep; 13(2):175-87. PubMed ID: 19372500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE
    J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life.
    Harpin VA
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i2-7. PubMed ID: 15665153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome of hyperactive children].
    Messerschmitt P
    Rev Prat; 2002 Nov; 52(18):2009-12. PubMed ID: 12602167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.
    Barkley RA
    Postgrad Med; 2008 Sep; 120(3):48-59. PubMed ID: 18824825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do attention deficits influence IQ assessment in children and adolescents with ADHD?
    Jepsen JR; Fagerlund B; Mortensen EL
    J Atten Disord; 2009 May; 12(6):551-62. PubMed ID: 18815437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the pharmacological treatment of children with ADHD: cognitive, behavioral, and social functioning differences.
    Graziano PA; Geffken GR; Lall AS
    J Atten Disord; 2011 Jul; 15(5):382-91. PubMed ID: 20495162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
    Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
    Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues and trends in the diagnosis and treatment of adults with ADHD.
    Cumyn L; Kolar D; Keller A; Hechtman L
    Expert Rev Neurother; 2007 Oct; 7(10):1375-90. PubMed ID: 17939773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.